Health plans keeping drug cost increases in check with programs that promote generics.
To counter the massive amount of drug company detailing and marketing that is partly responsible for driving up pharmaceutical costs, health plans and some independent practice associations are promoting the use of generics to physicians in their networks. While most physicians in capitated contracts don't directly benefit from the movement to encourage generics unless they have pharmacy risk, some health plans are paying physicians financial incentives to increase generic prescribing.
D000329:Advertising; D002204:Capitation Fee; D016527:Drug Costs; D004345:Drug Industry; D011307:Drug Prescriptions / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution; D006279:Health Maintenance Organizations / Q000191:economics*; D006801:Humans; D007193:Independent Practice Associations / Q000191:economics*; D010816:Physician Incentive Plans; D014481:United States
D016568:Drugs, Generic